{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:11:59Z","timestamp":1783771919002,"version":"3.55.0"},"publisher-location":"Cham","reference-count":148,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_18","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:41Z","timestamp":1783768601000},"page":"505-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of Nuclear Magnetic Resonance (NMR) to Study Cancer Metabolism"],"prefix":"10.1007","author":[{"given":"Catarina","family":"Freitas-Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Gafeira","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/METABO7020014","volume":"7","author":"S Alonezi","year":"2017","unstructured":"Alonezi S, Tusiimire J, Wallace J et al (2017) Metabolomic profiling of the synergistic effects of melittin in combination with cisplatin on ovarian cancer cells. Metabolites 7:14. https:\/\/doi.org\/10.3390\/METABO7020014","journal-title":"Metabolites"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1021\/ACS.JPROTEOME.5B00277\/SUPPL_FILE\/PR5B00277_SI_003.PDF","volume":"14","author":"A Amiot","year":"2015","unstructured":"Amiot A, Dona AC, Wijeyesekera A et al (2015) 1H NMR spectroscopy of fecal extracts enables detection of advanced colorectal neoplasia. J Proteome Res 14:3871\u20133881. https:\/\/doi.org\/10.1021\/ACS.JPROTEOME.5B00277\/SUPPL_FILE\/PR5B00277_SI_003.PDF","journal-title":"J Proteome Res"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S12276-018-0060-Y","volume":"50","author":"MR Antoniewicz","year":"2018","unstructured":"Antoniewicz MR (2018) A guide to 13C metabolic flux analysis for the cancer biologist. Exp Mol Med 50:1\u201313. https:\/\/doi.org\/10.1038\/S12276-018-0060-Y","journal-title":"Exp Mol Med"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/PNAS.1733835100","volume":"100","author":"JH Ardenkj\u00e6r-Larsen","year":"2003","unstructured":"Ardenkj\u00e6r-Larsen JH, Fridlund B, Gram A et al (2003) Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 100:10158\u201310163. https:\/\/doi.org\/10.1073\/PNAS.1733835100","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"111058","DOI":"10.1016\/J.EJRAD.2023.111058","volume":"167","author":"O Arponen","year":"2023","unstructured":"Arponen O, Wodtke P, Gallagher FA, Woitek R (2023) Hyperpolarised 13C-MRI using 13C-pyruvate in breast cancer: a review. Eur J Radiol 167:111058. https:\/\/doi.org\/10.1016\/J.EJRAD.2023.111058","journal-title":"Eur J Radiol"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"1158330","DOI":"10.3389\/fmolb.2023.115833010.3389","volume":"10","author":"G Bae","year":"2023","unstructured":"Bae G, Berezhnoy G, Koch A et al (2023) Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers. Front Mol Biosci 10:1158330. https:\/\/doi.org\/10.3389\/fmolb.2023.115833010.3389","journal-title":"Front Mol Biosci"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1021\/PR400859W","volume":"12","author":"N Bansal","year":"2013","unstructured":"Bansal N, Gupta A, Mitash N et al (2013) Low- and high-grade bladder cancer determination via human serum-based metabolomics approach. J Proteome Res 12:5839\u20135850. https:\/\/doi.org\/10.1021\/PR400859W","journal-title":"J Proteome Res"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02590529","volume":"8","author":"SJ Barton","year":"1999","unstructured":"Barton SJ, Howe FA, Tomlins AM et al (1999) Comparison of in vivo 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. Magn Reson Mater Phys Biol Med 8:121\u2013128. https:\/\/doi.org\/10.1007\/BF02590529","journal-title":"Magn Reson Mater Phys Biol Med"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"e61578","DOI":"10.1371\/JOURNAL.PONE.0061578","volume":"8","author":"TF Bathen","year":"2013","unstructured":"Bathen TF, Geurts B, Sitter B et al (2013) Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS ONE 8:e61578. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0061578","journal-title":"PLoS ONE"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/NPROT.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TMD et al (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692\u20132703. https:\/\/doi.org\/10.1038\/NPROT.2007.376","journal-title":"Nat Protoc"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/S10858-011-9489-1","volume":"49","author":"P Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Luchinat C et al (2011) Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 49:231\u2013243. https:\/\/doi.org\/10.1007\/S10858-011-9489-1","journal-title":"J Biomol NMR"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1158\/1078-0432.CCR-11-2929","volume":"18","author":"H Bertilsson","year":"2012","unstructured":"Bertilsson H, Tessem MB, Flatberg A et al (2012) Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples. Clin Cancer Res 18:3261\u20133269. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2929","journal-title":"Clin Cancer Res"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1021\/AC500979G","volume":"86","author":"K Bingol","year":"2014","unstructured":"Bingol K, Bruschweiler-Li L, Li DW, Bru\u00fcschweiler R (2014) Customized metabolomics database for the analysis of NMR 1H-1H TOCSY and 13C-1H HSQC-TOCSY spectra of complex mixtures. Anal Chem 86:5494\u20135501. https:\/\/doi.org\/10.1021\/AC500979G","journal-title":"Anal Chem"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.3390\/IJMS25147555","volume":"25","author":"\u0141 Boguszewicz","year":"2024","unstructured":"Boguszewicz \u0141, Biele\u0144 A, Jarczewski JD et al (2024) NMR-based metabolomics of blood serum in predicting response to induction chemotherapy in head and neck cancer\u2014a preliminary approach. Int J Mol Sci 25:7555. https:\/\/doi.org\/10.3390\/IJMS25147555","journal-title":"Int J Mol Sci"},{"key":"18_CR15","doi-asserted-by":"publisher","unstructured":"Bolanos MAC, Chinchalongporn V, Biswas RG et al (2024) Metabolic analysis in intact human-derived cerebral organoids by high-resolution magic-angle spinning NMR spectroscopy. bioRxiv https:\/\/doi.org\/10.1101\/2024.06.21.599412","DOI":"10.1101\/2024.06.21.599412"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO;2-I","volume":"13","author":"EA Boss","year":"2000","unstructured":"Boss EA, Moolenaar SH, Massuger L et al (2000) High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed 13:297\u2013305. https:\/\/doi.org\/10.1002\/1099-1492(200008)13:5<297::AID-NBM648>3.0.CO;2-I","journal-title":"NMR Biomed"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"e73076","DOI":"10.1371\/JOURNAL.PONE.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra S, Aziat F, Mandal R et al (2013) The human urine metabolome. PLoS ONE 8:e73076. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0073076","journal-title":"PLoS ONE"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"11171","DOI":"10.3390\/IJMS231911171","volume":"23","author":"J Brezmes","year":"2022","unstructured":"Brezmes J, Llambrich M, Cumeras R, Gum\u00e0 J (2022) Urine NMR metabolomics for precision oncology in colorectal cancer. Int J Mol Sci 23:11171. https:\/\/doi.org\/10.3390\/IJMS231911171","journal-title":"Int J Mol Sci"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"e1008184","DOI":"10.1371\/JOURNAL.PCBI.1008184","volume":"16","author":"D Cakmakci","year":"2020","unstructured":"Cakmakci D, Karakaslar EO, Ruhland E et al (2020) Machine learning assisted intraoperative assessment of brain tumor margins using HRMAS NMR spectroscopy. PLoS Comput Biol 16:e1008184. https:\/\/doi.org\/10.1371\/JOURNAL.PCBI.1008184","journal-title":"PLoS Comput Biol"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/NBM.1762","volume":"25","author":"MD Cao","year":"2012","unstructured":"Cao MD, Sitter B, Bathen TF et al (2012) Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR Biomed 25:369\u2013378. https:\/\/doi.org\/10.1002\/NBM.1762","journal-title":"NMR Biomed"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/CANCERS14205055","volume":"14","author":"MR Cardoso","year":"2022","unstructured":"Cardoso MR, Silva AAR, Talarico MCR et al (2022) Metabolomics by NMR combined with machine learning to predict neoadjuvant chemotherapy response for breast cancer. Cancers (Basel) 14:5055. https:\/\/doi.org\/10.3390\/CANCERS14205055","journal-title":"Cancers (Basel)"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1039\/C8AY00830B","volume":"10","author":"M Cassi\u00e8de","year":"2018","unstructured":"Cassi\u00e8de M, Mercier P, Shipley PR et al (2018) Comparison of computational approaches for identification and quantification of urinary metabolites in 1H NMR spectra. Anal Methods 10:2129\u20132137. https:\/\/doi.org\/10.1039\/C8AY00830B","journal-title":"Anal Methods"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.radonc.2015.07.037","volume":"117","author":"Y Chai","year":"2015","unstructured":"Chai Y, Wang J, Wang T et al (2015) Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms. Radiother Oncol 117:294\u2013301. https:\/\/doi.org\/10.1016\/j.radonc.2015.07.037","journal-title":"Radiother Oncol"},{"key":"18_CR24","unstructured":"Chang S (2024) Study details | Hyperpolarized carbon-13 (13C) pyruvate imaging in patients with glioblastoma | ClinicalTrials.gov. University of California, San Francisco. https:\/\/www.clinicaltrials.gov\/study\/NCT04019002. Accessed 31 Jul 2025"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/CANCERS17132211","volume":"17","author":"HY Chen","year":"2025","unstructured":"Chen HY, de Kouchkovsky I, Bok RA et al (2025) Multivariate framework of metabolism in advanced prostate cancer using whole abdominal and pelvic hyperpolarized 13C MRI\u2014a correlative study with clinical outcomes. Cancers (Basel) 17:2211. https:\/\/doi.org\/10.3390\/CANCERS17132211","journal-title":"Cancers (Basel)"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1111\/AJCO.12598","volume":"13","author":"W Chen","year":"2017","unstructured":"Chen W, Lu S, Wang G et al (2017) Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS 1H NMR) and multivariate data analysis. Asia Pac J Clin Oncol 13:e232\u2013e238. https:\/\/doi.org\/10.1111\/AJCO.12598","journal-title":"Asia Pac J Clin Oncol"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"e51712","DOI":"10.1371\/JOURNAL.PONE.0051712","volume":"7","author":"JS Choi","year":"2012","unstructured":"Choi JS, Baek HM, Kim S et al (2012) HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. PLoS ONE 7:e51712. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0051712","journal-title":"PLoS ONE"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/CANCERS12082147","volume":"12","author":"FK Choudhury","year":"2020","unstructured":"Choudhury FK, Lavender Hackman G, Lodi A, Tiziani S (2020) Stable isotope tracing metabolomics to investigate the metabolic activity of bioactive compounds for cancer prevention and treatment. Cancers (Basel) 12:2147. https:\/\/doi.org\/10.3390\/CANCERS12082147","journal-title":"Cancers (Basel)"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3390\/MOLECULES25153502","volume":"25","author":"LDel Coco","year":"2020","unstructured":"Coco L Del, Majellaro M, Boccarelli A et al (2020) Novel antiproliferative biphenyl nicotinamide: NMR metabolomic study of its effect on the MCF-7 cell in comparison with cisplatin and vinblastine. Molecules 25:3502. https:\/\/doi.org\/10.3390\/MOLECULES25153502","journal-title":"Molecules"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1158\/2326-6066.CIR-19-0403","volume":"8","author":"N Cortese","year":"2020","unstructured":"Cortese N, Capretti G, Barbagallo M et al (2020) Metabolome of pancreatic juice delineates distinct clinical profiles of pancreatic cancer and reveals a link between glucose metabolism and PD-1+Cells. Cancer Immunol Res 8:493\u2013505. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0403","journal-title":"Cancer Immunol Res"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.3390\/MOLECULES25215128","volume":"25","author":"AA Crook","year":"2020","unstructured":"Crook AA, Powers R (2020) Quantitative NMR-based biomedical metabolomics: current status and applications. Molecules 25:5128. https:\/\/doi.org\/10.3390\/MOLECULES25215128","journal-title":"Molecules"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1016\/S0021-9258(18)48107-0","volume":"262","author":"PF Daly","year":"1987","unstructured":"Daly PF, Lyon RC, Faustino PJ, Cohen JS (1987) Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J Biol Chem 262:14875\u201314878.\u2002https:\/\/doi.org\/10.1016\/S0021-9258(18)48107-0","journal-title":"J Biol Chem"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1245\/S10434-012-2686-7","volume":"20","author":"VW Davis","year":"2013","unstructured":"Davis VW, Schiller DE, Eurich D et al (2013) Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature. Ann Surg Oncol 20:415\u2013423. https:\/\/doi.org\/10.1245\/S10434-012-2686-7","journal-title":"Ann Surg Oncol"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3390\/MOLECULES24122240","volume":"24","author":"F De Castro","year":"2019","unstructured":"De Castro F, Benedetti M, Del Coco L, Fanizzi FP (2019) NMR-based metabolomics in metal-based drug research. Molecules 24:2240. https:\/\/doi.org\/10.3390\/MOLECULES24122240","journal-title":"Molecules"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/CANCERS15020531\/S1","volume":"15","author":"J De los Santos-Jim\u00e9nez","year":"2023","unstructured":"De los Santos-Jim\u00e9nez J, Rosales T, Ko B et al (2023) Metabolic adjustments following glutaminase inhibition by CB-839 in glioblastoma cell lines. Cancers (Basel) 15:531. https:\/\/doi.org\/10.3390\/CANCERS15020531\/S1","journal-title":"Cancers (Basel)"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"e230005","DOI":"10.1148\/RYCAN.230005","volume":"5","author":"SS Deen","year":"2023","unstructured":"Deen SS, Rooney C, Shinozaki A et al (2023) Hyperpolarized carbon 13 MRI: clinical applications and future directions in oncology. Radiol Imaging Cancer 5:e230005. https:\/\/doi.org\/10.1148\/RYCAN.230005","journal-title":"Radiol Imaging Cancer"},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymben.2019.12.005","volume":"59","author":"S Deja","year":"2020","unstructured":"Deja S, Fu X, Fletcher JA et al (2020) Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver. Metab Eng 59:1\u201314. https:\/\/doi.org\/10.1016\/j.ymben.2019.12.005","journal-title":"Metab Eng"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/J.JPBA.2014.08.020","volume":"100","author":"S Deja","year":"2014","unstructured":"Deja S, Porebska I, Kowal A et al (2014) Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. J Pharm Biomed Anal 100:369\u2013380. https:\/\/doi.org\/10.1016\/J.JPBA.2014.08.020","journal-title":"J Pharm Biomed Anal"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.PNMRS.2011.11.002","volume":"62","author":"IF Duarte","year":"2012","unstructured":"Duarte IF, Gil AM (2012) Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Prog Nucl Magn Reson Spectrosc 62:51\u201374. https:\/\/doi.org\/10.1016\/J.PNMRS.2011.11.002","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1021\/MP400335K","volume":"10","author":"IF Duarte","year":"2013","unstructured":"Duarte IF, Ladeirinha AF, Lamego I et al (2013) Potential markers of cisplatin treatment response unveiled by NMR metabolomics of human lung cells. Mol Pharm 10:4242\u20134251. https:\/\/doi.org\/10.1021\/MP400335K","journal-title":"Mol Pharm"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1021\/PR100635N","volume":"9","author":"IF Duarte","year":"2010","unstructured":"Duarte IF, Lamego I, Marques J et al (2010) Nuclear magnetic resonance (NMR) study of the effect of cisplatin on the metabolic profile of MG-63 osteosarcoma cells. J Proteome Res 9:5877\u20135886. https:\/\/doi.org\/10.1021\/PR100635N","journal-title":"J Proteome Res"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/S12551-012-0099-2","volume":"5","author":"P Dutta","year":"2013","unstructured":"Dutta P, Martinez GV, Gillies RJ (2013) A new horizon of DNP technology: application to in-vivo 13C magnetic resonance spectroscopy and imaging. Biophys Rev 5:281. https:\/\/doi.org\/10.1007\/S12551-012-0099-2","journal-title":"Biophys Rev"},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.COPBIO.2016.08.005","volume":"43","author":"HR Eghbalnia","year":"2017","unstructured":"Eghbalnia HR, Romero PR, Westler WM et al (2017) Increasing rigor in NMR-based metabolomics through validated and open source tools. Curr Opin Biotechnol 43:56\u201361. https:\/\/doi.org\/10.1016\/J.COPBIO.2016.08.005","journal-title":"Curr Opin Biotechnol"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2049-3002-2-16","volume":"2","author":"R Elkholi","year":"2014","unstructured":"Elkholi R, Renault TT, Serasinghe MN, Chipuk JE (2014) Putting the pieces together: how is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy? Cancer Metab 2:16. https:\/\/doi.org\/10.1186\/2049-3002-2-16","journal-title":"Cancer Metab"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.PNMRS.2021.04.002","volume":"126\u2013127","author":"SJ Elliott","year":"2021","unstructured":"Elliott SJ, Stern Q, Ceillier M et al (2021) Practical dissolution dynamic nuclear polarization. Prog Nucl Magn Reson Spectrosc 126\u2013127:59\u2013100. https:\/\/doi.org\/10.1016\/J.PNMRS.2021.04.002","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"18_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/CELLS13040305","volume":"13","author":"C Freitas-Dias","year":"2024","unstructured":"Freitas-Dias C, Gon\u00e7alves F, Martins F et al (2024) Interaction between NSCLC Cells, CD8+ T-cells and immune checkpoint inhibitors potentiates coagulation and promotes metabolic remodeling\u2014new cues on CAT-VTE. Cells 13:305. https:\/\/doi.org\/10.3390\/CELLS13040305","journal-title":"Cells"},{"key":"18_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/NBM.1361","volume":"22","author":"C Gabellieri","year":"2009","unstructured":"Gabellieri C, Beloueche-Babari M, Jamin Y et al (2009) Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR. NMR Biomed 22:456\u2013461. https:\/\/doi.org\/10.1002\/NBM.1361","journal-title":"NMR Biomed"},{"key":"18_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2174\/138620712802650522","volume":"15","author":"T Gebregiworgis","year":"2012","unstructured":"Gebregiworgis T, Powers R (2012) Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High Throughput Screen 15:595\u2013610. https:\/\/doi.org\/10.2174\/138620712802650522","journal-title":"Comb Chem High Throughput Screen"},{"key":"18_CR49","doi-asserted-by":"publisher","first-page":"12512","DOI":"10.1039\/D2DT02068H","volume":"51","author":"V Ghini","year":"2022","unstructured":"Ghini V, Magherini F, Massai L et al (2022) Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs. Dalton Trans 51:12512\u201312523. https:\/\/doi.org\/10.1039\/D2DT02068H","journal-title":"Dalton Trans"},{"key":"18_CR50","doi-asserted-by":"publisher","first-page":"e62375","DOI":"10.1371\/JOURNAL.PONE.0062375","volume":"8","author":"GF Giske\u00f8deg\u00e5rd","year":"2013","unstructured":"Giske\u00f8deg\u00e5rd GF, Bertilsson H, Seln\u00e6s KM et al (2013) Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness. PLoS ONE 8:e62375. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0062375","journal-title":"PLoS ONE"},{"key":"18_CR51","doi-asserted-by":"publisher","first-page":"e3927","DOI":"10.1002\/NBM.3927","volume":"32","author":"GF Giske\u00f8deg\u00e5rd","year":"2019","unstructured":"Giske\u00f8deg\u00e5rd GF, Madssen TS, Euceda LR et al (2019) NMR-based metabolomics of biofluids in cancer. NMR Biomed 32:e3927. https:\/\/doi.org\/10.1002\/NBM.3927","journal-title":"NMR Biomed"},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"e3862","DOI":"10.1002\/NBM.3862","volume":"31","author":"M Gogiashvili","year":"2018","unstructured":"Gogiashvili M, Horsch S, Marchan R et al (2018) Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed 31:e3862. https:\/\/doi.org\/10.1002\/NBM.3862","journal-title":"NMR Biomed"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/METABO9020019","volume":"9","author":"M Gogiashvili","year":"2019","unstructured":"Gogiashvili M, Nowacki J, Hergenr\u00f6der R et al (2019) HR-MAS NMR based quantitative metabolomics in breast cancer. Metabolites 9:19. https:\/\/doi.org\/10.3390\/METABO9020019","journal-title":"Metabolites"},{"key":"18_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/JMRI.29162","volume":"60","author":"JW Gordon","year":"2024","unstructured":"Gordon JW, Chen HY, Nickles T et al (2024) Hyperpolarized 13C metabolic MRI of patients with pancreatic ductal adenocarcinoma. J Magn Reson Imaging 60:741\u2013749. https:\/\/doi.org\/10.1002\/JMRI.29162","journal-title":"J Magn Reson Imaging"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/2213235X113019990005","volume":"1","author":"GA Gowda","year":"2013","unstructured":"Gowda GA, Raftery D (2013) Biomarker discovery and translation in metabolomics. Current metabolomics\u20091:227\u2013240.\u2009https:\/\/doi.org\/10.2174\/2213235X113019990005","journal-title":"Current metabolomics"},{"key":"18_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-51652-9_2","volume-title":"Cancer metabolomics. Advances in experimental medicine and biology","author":"GA Gowda","year":"2021","unstructured":"Gowda GA, Raftery D (2021) NMR-based metabolomics. In: Hu S (ed) Cancer metabolomics. Advances in experimental medicine and biology. Springer, Cham, pp 19\u201337"},{"key":"18_CR57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1021\/ACS.ANALCHEM.6B04420","volume":"89","author":"GAN Gowda","year":"2016","unstructured":"Gowda GAN, Raftery D (2016) Recent advances in NMR-based metabolomics. Anal Chem 89:490\u2013510. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.6B04420","journal-title":"Anal Chem"},{"key":"18_CR58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/S11306-017-1269-9\/METRICS","volume":"13","author":"G Gra\u00e7a","year":"2017","unstructured":"Gra\u00e7a G, Desterro J, Sousa J et al (2017) Identification of putative biomarkers for leptomeningeal invasion in B-cell non-Hodgkin lymphoma by NMR metabolomics. Metabolomics 13:136. https:\/\/doi.org\/10.1007\/S11306-017-1269-9\/METRICS","journal-title":"Metabolomics"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.chembiol.2018.09.004","volume":"25","author":"N Grankvist","year":"2018","unstructured":"Grankvist N, Watrous JD, Lagerborg KA et al (2018) Profiling the metabolism of human cells by deep 13C labeling. Cell Chem Biol 25:1419\u20131427.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2018.09.004","journal-title":"Cell Chem Biol"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/S13058-019-1141-0","volume":"21","author":"MT Grinde","year":"2019","unstructured":"Grinde MT, Hilmarsdottir B, Tunset HM et al (2019) Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer. Breast Cancer Res 21:61. https:\/\/doi.org\/10.1186\/S13058-019-1141-0","journal-title":"Breast Cancer Res"},{"key":"18_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.ACA.2010.11.040","volume":"686","author":"H Gu","year":"2011","unstructured":"Gu H, Pan Z, Xi B et al (2011) Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Anal Chim Acta 686:57\u201363. https:\/\/doi.org\/10.1016\/J.ACA.2010.11.040","journal-title":"Anal Chim Acta"},{"key":"18_CR62","first-page":"560","volume":"5","author":"H Gutte","year":"2015","unstructured":"Gutte H, Hansen AE, Johannesen HH et al (2015) The use of dynamic nuclear polarization 13C-pyruvate MRS in cancer. Am J Nucl Med Mol Imaging 5:560","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"18_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/S44324-024-00017-2","volume":"2","author":"NG Hammond","year":"2024","unstructured":"Hammond NG, Cameron RB, Faubert B (2024) Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models. npj Metab Health Dis 2:11. https:\/\/doi.org\/10.1038\/S44324-024-00017-2","journal-title":"npj Metab Health Dis"},{"key":"18_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejrad.2018.02.028","volume":"103","author":"AE Hansen","year":"2018","unstructured":"Hansen AE, Gutte H, Holst P et al (2018) Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients. Eur J Radiol 103:6\u201312. https:\/\/doi.org\/10.1016\/j.ejrad.2018.02.028","journal-title":"Eur J Radiol"},{"key":"18_CR65","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3892\/etm.2012.509","volume":"3","author":"A Hasim","year":"2012","unstructured":"Hasim A, Ali M, Mamtimin B et al (2012) Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by 1H NMR spectroscopy. Exp Ther Med 3:945\u2013951","journal-title":"Exp Ther Med"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"e2014631118","DOI":"10.1073\/PNAS.2014631118","volume":"118","author":"F Hesse","year":"2021","unstructured":"Hesse F, Somai V, Kreis F et al (2021) Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging. Proc Natl Acad Sci USA 118:e2014631118. https:\/\/doi.org\/10.1073\/PNAS.2014631118","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR67","doi-asserted-by":"publisher","first-page":"656851","DOI":"10.3389\/FONC.2021.656851","volume":"11","author":"A Hip\u00f3lito","year":"2021","unstructured":"Hip\u00f3lito A, Martins F, Mendes C et al (2021) Molecular and metabolic reprogramming: pulling the strings toward tumor metastasis. Front Oncol 11:656851. https:\/\/doi.org\/10.3389\/FONC.2021.656851","journal-title":"Front Oncol"},{"key":"18_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ANTIOX13010051","volume":"13","author":"A Hip\u00f3lito","year":"2024","unstructured":"Hip\u00f3lito A, Mendes C, Martins F et al (2024) H2S-synthesizing enzymes are putative determinants in lung cancer management toward personalized medicine. Antioxidants 13:51. https:\/\/doi.org\/10.3390\/ANTIOX13010051","journal-title":"Antioxidants"},{"key":"18_CR69","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1021\/PR3010106","volume":"12","author":"B Jim\u00e9nez","year":"2013","unstructured":"Jim\u00e9nez B, Mirnezami R, Kinross J et al (2013) 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic \u201cfield-effects\u201d enables colorectal cancer staging and prognostication. J Proteome Res 12:959\u2013968. https:\/\/doi.org\/10.1021\/PR3010106","journal-title":"J Proteome Res"},{"key":"18_CR70","doi-asserted-by":"publisher","first-page":"1480613","DOI":"10.3389\/FONC.2024.1480613","volume":"14","author":"MMG Kes","year":"2024","unstructured":"Kes MMG, Berkers CR, Drost J (2024) Bridging the gap: advancing cancer cell culture to reveal key metabolic targets. Front Oncol 14:1480613. https:\/\/doi.org\/10.3389\/FONC.2024.1480613","journal-title":"Front Oncol"},{"key":"18_CR71","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1002\/CAM4.5083","volume":"12","author":"JH Kim","year":"2023","unstructured":"Kim JH, An YJ, Kim TM et al (2023) Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: correlation with MR imaging characteristics. Cancer Med 12:4679\u20134689. https:\/\/doi.org\/10.1002\/CAM4.5083","journal-title":"Cancer Med"},{"key":"18_CR72","doi-asserted-by":"publisher","first-page":"892195","DOI":"10.3389\/FONC.2022.892195","volume":"12","author":"A Klepinin","year":"2022","unstructured":"Klepinin A, Miller S, Reile I et al (2022) Stable isotope tracing uncovers reduced \u03b3\/\u03b2-ATP turnover and metabolic flux through mitochondrial-linked phosphotransfer circuits in aggressive breast cancer cells. Front Oncol 12:892195. https:\/\/doi.org\/10.3389\/FONC.2022.892195","journal-title":"Front Oncol"},{"key":"18_CR73","doi-asserted-by":"publisher","first-page":"13485","DOI":"10.1021\/ACS.ANALCHEM.1C02221","volume":"93","author":"R Knitsch","year":"2021","unstructured":"Knitsch R, AlWahsh M, Raschke H et al (2021) In vitro spatio-temporal NMR metabolomics of living 3D cell models. Anal Chem 93:13485\u201313494. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.1C02221","journal-title":"Anal Chem"},{"key":"18_CR74","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/MRM.22677","volume":"65","author":"RA Komoroski","year":"2011","unstructured":"Komoroski RA, Holder JC, Pappas AA, Finkbeiner AE (2011) 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia. Magn Reson Med 65:911\u2013913. https:\/\/doi.org\/10.1002\/MRM.22677","journal-title":"Magn Reson Med"},{"key":"18_CR75","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.devcel.2016.08.014","volume":"38","author":"K Kretzschmar","year":"2016","unstructured":"Kretzschmar K, Clevers H (2016) Organoids: modeling development and the stem cell niche in a dish. Dev Cell 38:590\u2013600. https:\/\/doi.org\/10.1016\/j.devcel.2016.08.014","journal-title":"Dev Cell"},{"key":"18_CR76","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1021\/PR5011108","volume":"14","author":"D Kumar","year":"2015","unstructured":"Kumar D, Gupta A, Mandhani A, Sankhwar SN (2015) Metabolomics-derived prostate cancer biomarkers: fact or fiction?. J Proteome Res 14:1455\u20131464. https:\/\/doi.org\/10.1021\/PR5011108","journal-title":"J Proteome Res"},{"key":"18_CR77","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/PROS.23198","volume":"76","author":"D Kumar","year":"2016","unstructured":"Kumar D, Gupta A, Mandhani A, Sankhwar SN (2016) NMR spectroscopy of filtered serum of prostate cancer: a new frontier in metabolomics. Prostate 76:1106\u20131119. https:\/\/doi.org\/10.1002\/PROS.23198","journal-title":"Prostate"},{"key":"18_CR78","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1021\/PR500907D","volume":"13","author":"I Lamego","year":"2014","unstructured":"Lamego I, Duarte IF, Marques MPM, Gil AM (2014) Metabolic markers of MG-63 osteosarcoma cell line response to doxorubicin and methotrexate treatment: comparison to cisplatin. J Proteome Res 13:6033\u20136045. https:\/\/doi.org\/10.1021\/PR500907D","journal-title":"J Proteome Res"},{"key":"18_CR79","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/IUB.17","volume":"60","author":"AN Lane","year":"2008","unstructured":"Lane AN, Fan TWM, Higashi RM (2008) Stable isotope-assisted metabolomics in cancer research. IUBMB Life 60:124\u2013129. https:\/\/doi.org\/10.1002\/IUB.17","journal-title":"IUBMB Life"},{"key":"18_CR80","doi-asserted-by":"publisher","first-page":"115322","DOI":"10.1016\/J.TRAC.2018.11.020","volume":"120","author":"AN Lane","year":"2019","unstructured":"Lane AN, Higashi RM, Fan TWM (2019) NMR and MS-based stable isotope-resolved metabolomics and applications in cancer metabolism. TrAC Trends Anal Chem 120:115322. https:\/\/doi.org\/10.1016\/J.TRAC.2018.11.020","journal-title":"TrAC Trends Anal Chem"},{"key":"18_CR81","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/J.JMR.2017.05.008","volume":"281","author":"PM Lefebvre","year":"2017","unstructured":"Lefebvre PM, Van Reeth E, Ratiney H et al (2017) Active control of the spatial MRI phase distribution with optimal control theory. J Magn Reson 281:82\u201393. https:\/\/doi.org\/10.1016\/J.JMR.2017.05.008","journal-title":"J Magn Reson"},{"key":"18_CR82","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/METABO15040244","volume":"15","author":"I Lemos","year":"2025","unstructured":"Lemos I, Freitas-Dias C, Hip\u00f3lito A et al (2025a) Cell-free DNA (cfDNA) regulates metabolic remodeling in the ES-2 ovarian carcinoma cell line, influencing cell proliferation, quiescence, and chemoresistance in a cell-of-origin-specific manner. Metabolites 15:244. https:\/\/doi.org\/10.3390\/METABO15040244","journal-title":"Metabolites"},{"key":"18_CR83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/METABO15040227","volume":"15","author":"I Lemos","year":"2025","unstructured":"Lemos I, Freitas-Dias C, Hip\u00f3lito A et al (2025b) Cell-free DNA (cfDNA) regulates metabolic remodeling, sustaining proliferation, quiescence, and migration in MDA-MB-231, a triple-negative breast carcinoma (TNBC) cell line. Metabolites 15:227. https:\/\/doi.org\/10.3390\/METABO15040227","journal-title":"Metabolites"},{"key":"18_CR84","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/978-1-0716-4116-3_26","volume":"2855","author":"P Lin","year":"2025","unstructured":"Lin P, Lane AN, Fan TWM (2025) NMR-based stable isotope tracing of cancer metabolism. Methods Mol Biol 2855:457\u2013504. https:\/\/doi.org\/10.1007\/978-1-0716-4116-3_26","journal-title":"Methods Mol Biol"},{"key":"18_CR85","doi-asserted-by":"publisher","first-page":"29454","DOI":"10.18632\/ONCOTARGET.8762","volume":"7","author":"Y Lin","year":"2016","unstructured":"Lin Y, Ma C, Liu C et al (2016) NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget 7:29454\u201329464. https:\/\/doi.org\/10.18632\/ONCOTARGET.8762","journal-title":"Oncotarget"},{"key":"18_CR86","doi-asserted-by":"publisher","first-page":"82823","DOI":"10.18632\/ONCOTARGET.20294","volume":"8","author":"F Lopes-Coelho","year":"2017","unstructured":"Lopes-Coelho F, Nunes C, Gouveia-Fernandes S et al (2017) Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells. Oncotarget 8:82823. https:\/\/doi.org\/10.18632\/ONCOTARGET.20294","journal-title":"Oncotarget"},{"key":"18_CR87","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/leu.2009.295","volume":"24","author":"DA MacIntyre","year":"2010","unstructured":"MacIntyre DA, Jim\u00e9nez B, Lewintre EJ et al (2010) Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 24:788\u2013797. https:\/\/doi.org\/10.1038\/leu.2009.295","journal-title":"Leukemia"},{"key":"18_CR88","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2020.03.009","volume":"6","author":"D Mahadevan","year":"2020","unstructured":"Mahadevan D, Rogers GC (2020) Janus face of drug-induced tetraploidy in non-Hodgkin lymphoma. Trends Cancer 6:627\u2013630. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.009","journal-title":"Trends Cancer"},{"key":"18_CR89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.COPBIO.2016.08.001","volume":"43","author":"JL Markley","year":"2017","unstructured":"Markley JL, Br\u00fcschweiler R, Edison AS et al (2017) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34\u201340. https:\/\/doi.org\/10.1016\/J.COPBIO.2016.08.001","journal-title":"Curr Opin Biotechnol"},{"key":"18_CR90","doi-asserted-by":"publisher","first-page":"e4569","DOI":"10.1002\/NBM.4569","volume":"34","author":"S Markovic","year":"2021","unstructured":"Markovic S, Roussel T, Agemy L et al (2021) Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models. NMR Biomed 34:e4569. https:\/\/doi.org\/10.1002\/NBM.4569","journal-title":"NMR Biomed"},{"key":"18_CR91","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41417-025-00906-8","volume":"32","author":"F Martins","year":"2025","unstructured":"Martins F, Arada R, Barros H et al (2025) Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM). Cancer Gene Ther 32:690\u2013705. https:\/\/doi.org\/10.1038\/s41417-025-00906-8","journal-title":"Cancer Gene Ther"},{"key":"18_CR92","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3390\/BIOMEDICINES11072041","volume":"11","author":"F Martins","year":"2023","unstructured":"Martins F, van der Kellen D, Gon\u00e7alves LG, Serpa J (2023) Metabolic profiles point out metabolic pathways pivotal in two glioblastoma (GBM) cell lines, U251 and U-87MG. Biomedicines 11:2041. https:\/\/doi.org\/10.3390\/BIOMEDICINES11072041","journal-title":"Biomedicines"},{"key":"18_CR93","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1210\/JC.2019-01101","volume":"104","author":"RG Martins","year":"2019","unstructured":"Martins RG, Gon\u00e7alves LG, Cunha N, Bugalho MJ (2019) Metabolomic urine profile: searching for new biomarkers of SDHx-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 104:5467\u20135477. https:\/\/doi.org\/10.1210\/JC.2019-01101","journal-title":"J Clin Endocrinol Metab"},{"key":"18_CR94","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1731::AID-CNCR20>3.0.CO;2-4","volume":"82","author":"LFAG Massuger","year":"2000","unstructured":"Massuger LFAG, Van Vierzen PBJ, Engelke U et al (2000) 1H-magnetic resonance spectroscopy. Cancer 82:1726\u20131730. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19980501)82:9<1731::AID-CNCR20>3.0.CO;2-4","journal-title":"Cancer"},{"key":"18_CR95","doi-asserted-by":"publisher","first-page":"20240752","DOI":"10.1042\/BSR20240752\/234693","volume":"44","author":"C Mendes","year":"2024","unstructured":"Mendes C, Lemos I, Hip\u00f3lito A et al (2024) Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells. Biosci Rep 44:20240752. https:\/\/doi.org\/10.1042\/BSR20240752\/234693","journal-title":"Biosci Rep"},{"key":"18_CR96","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1021\/ACS.JPROTEOME.0C00990","volume":"20","author":"L Mich\u00e1lkov\u00e1","year":"2021","unstructured":"Mich\u00e1lkov\u00e1 L, Horn\u00edk \u0160, S\u00fdkora J et al (2021) Early detection of pancreatic cancer in type 2 diabetes mellitus patients based on 1H NMR metabolomics. J Proteome Res 20:1744\u20131753. https:\/\/doi.org\/10.1021\/ACS.JPROTEOME.0C00990","journal-title":"J Proteome Res"},{"key":"18_CR97","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/SLA.0B013E31829D5C45","volume":"259","author":"R Mirnezami","year":"2014","unstructured":"Mirnezami R, Jim\u00e9nez B, Li JV et al (2014) Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann Surg 259:1138\u20131149. https:\/\/doi.org\/10.1097\/SLA.0B013E31829D5C45","journal-title":"Ann Surg"},{"key":"18_CR98","doi-asserted-by":"publisher","first-page":"198ra108","DOI":"10.1126\/SCITRANSLMED.3006070","volume":"5","author":"SJ Nelson","year":"2013","unstructured":"Nelson SJ, Kurhanewicz J, Vigneron DB et al (2013) Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate. Sci Transl Med 5:198ra108. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3006070","journal-title":"Sci Transl Med"},{"key":"18_CR99","doi-asserted-by":"publisher","first-page":"722412","DOI":"10.3389\/FCELL.2021.722412","volume":"9","author":"SC Nunes","year":"2021","unstructured":"Nunes SC, Ramos C, Santos I et al (2021) Cysteine boosts fitness under hypoxia-mimicked conditions in ovarian cancer by metabolic reprogramming. Front Cell Dev Biol 9:722412. https:\/\/doi.org\/10.3389\/FCELL.2021.722412","journal-title":"Front Cell Dev Biol"},{"key":"18_CR100","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/METABO13090989","volume":"13","author":"SC Nunes","year":"2023","unstructured":"Nunes SC, Sousa J, Silva F et al (2023) Peripheral blood serum NMR metabolomics is a powerful tool to discriminate benign and malignant ovarian tumors. Metabolites 13:989. https:\/\/doi.org\/10.3390\/METABO13090989","journal-title":"Metabolites"},{"key":"18_CR101","doi-asserted-by":"publisher","first-page":"1082841","DOI":"10.3389\/FONC.2023.1082841","volume":"13","author":"T Ouyang","year":"2023","unstructured":"Ouyang T, Ma C, Zhao Y et al (2023) 1H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer. Front Oncol 13:1082841. https:\/\/doi.org\/10.3389\/FONC.2023.1082841","journal-title":"Front Oncol"},{"key":"18_CR102","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/S11306-012-0483-8","volume":"9","author":"X Pan","year":"2013","unstructured":"Pan X, Wilson M, McConville C et al (2013) Increased unsaturation of lipids in cytoplasmic lipid droplets in DAOY cancer cells in response to cisplatin treatment. Metabolomics 9:722\u2013729. https:\/\/doi.org\/10.1007\/S11306-012-0483-8","journal-title":"Metabolomics"},{"key":"18_CR103","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1021\/PR200114V","volume":"10","author":"X Pan","year":"2011","unstructured":"Pan X, Wilson M, Mirbahai L et al (2011) In vitro metabonomic study detects increases in UDP-GlcNAc and UDP-GalNAc, as early phase markers of cisplatin treatment response in brain tumor cells. J Proteome Res 10:3493\u20133500. https:\/\/doi.org\/10.1021\/PR200114V","journal-title":"J Proteome Res"},{"key":"18_CR104","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/PROS.24670","volume":"84","author":"J Panach-Navarrete","year":"2024","unstructured":"Panach-Navarrete J, Gonz\u00e1lez-Marrachelli V, Morales-Tatay JM et al (2024) Metabolic analysis using HR-MAS in prostate tissue for prostate cancer diagnosis. Prostate 84:549\u2013559. https:\/\/doi.org\/10.1002\/PROS.24670","journal-title":"Prostate"},{"key":"18_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CMET.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/J.CMET.2015.12.006","journal-title":"Cell Metab"},{"key":"18_CR106","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.2174\/0929867326666190816232330","volume":"27","author":"MG Perrone","year":"2019","unstructured":"Perrone MG, Luisi O, De Grassi A et al (2019) Translational theragnosis of ovarian cancer: where do we stand?. Curr Med Chem 27:5675\u20135715. https:\/\/doi.org\/10.2174\/0929867326666190816232330","journal-title":"Curr Med Chem"},{"key":"18_CR107","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/MRM.27103","volume":"80","author":"T Platt","year":"2018","unstructured":"Platt T, Umathum R, Fiedler TM et al (2018) In vivo self-gated 23Na MRI at 7 T using an oval-shaped body resonator. Magn Reson Med 80:1005\u20131019. https:\/\/doi.org\/10.1002\/MRM.27103","journal-title":"Magn Reson Med"},{"key":"18_CR108","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.21037\/JTD-20-3075","volume":"13","author":"D Polanco","year":"2021","unstructured":"Polanco D, Pinilla L, Gracia-Lavedan E et al (2021) Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study. J Thorac Dis 13:1494. https:\/\/doi.org\/10.21037\/JTD-20-3075","journal-title":"J Thorac Dis"},{"key":"18_CR109","doi-asserted-by":"publisher","first-page":"e16957","DOI":"10.1371\/JOURNAL.PONE.0016957","volume":"6","author":"N Psychogios","year":"2011","unstructured":"Psychogios N, Hau DD, Peng J et al (2011) The human serum metabolome. PLoS ONE 6:e16957. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0016957","journal-title":"PLoS ONE"},{"key":"18_CR110","doi-asserted-by":"publisher","first-page":"12798","DOI":"10.1038\/S41598-019-49208-8","volume":"9","author":"B Ramirez","year":"2019","unstructured":"Ramirez B, Durst MA, Lavie A, Caffrey M (2019) NMR-based metabolite studies with 15N amino acids. Sci Rep 9:12798. https:\/\/doi.org\/10.1038\/S41598-019-49208-8","journal-title":"Sci Rep"},{"key":"18_CR111","doi-asserted-by":"publisher","first-page":"742859","DOI":"10.3389\/FMOLB.2021.742859","volume":"8","author":"K Resendiz-Acevedo","year":"2021","unstructured":"Resendiz-Acevedo K, Garc\u00eda-Aguilera ME, Esturau-Escofet N, Ruiz-Azuara L (2021) 1H-NMR metabolomics study of the effect of cisplatin and casiopeina IIgly on MDA-MB-231 breast tumor cells. Front Mol Biosci 8:742859. https:\/\/doi.org\/10.3389\/FMOLB.2021.742859","journal-title":"Front Mol Biosci"},{"key":"18_CR112","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/S42003-024-07277-0","volume":"7","author":"A Reyes-Oliveras","year":"2024","unstructured":"Reyes-Oliveras A, Ellis AE, Sheldon RD, Haab B (2024) Metabolomics and 13C labelled glucose tracing to identify carbon incorporation into aberrant cell membrane glycans in cancer. Commun Biol 7:1576. https:\/\/doi.org\/10.1038\/S42003-024-07277-0","journal-title":"Commun Biol"},{"key":"18_CR113","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/PR9006574","volume":"9","author":"CM Rocha","year":"2010","unstructured":"Rocha CM, Barros AS, Gil AM et al (2010) Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 9:319\u2013332. https:\/\/doi.org\/10.1021\/PR9006574","journal-title":"J Proteome Res"},{"key":"18_CR114","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2144\/000113133","volume":"46","author":"U Roessner","year":"2009","unstructured":"Roessner U, Bowne J (2009) What is metabolomics all about?. Biotechniques 46:363\u2013365. https:\/\/doi.org\/10.2144\/000113133","journal-title":"Biotechniques"},{"key":"18_CR115","doi-asserted-by":"publisher","first-page":"107405","DOI":"10.1016\/J.JMR.2023.107405","volume":"349","author":"G Rogers","year":"2023","unstructured":"Rogers G, Barker S, Sharma M et al (2023) Operando NMR metabolomics of a microfluidic cell culture. J Magn Reson 349:107405. https:\/\/doi.org\/10.1016\/J.JMR.2023.107405","journal-title":"J Magn Reson"},{"key":"18_CR116","doi-asserted-by":"publisher","unstructured":"R\u00f6\u00dfler P, Ruckstuhl M, L\u00f6bbert A et al (2024) Human cells for human proteins: isotope labeling in mammalian cells for functional NMR studies of disease-relevant proteins. bioRxiv https:\/\/doi.org\/10.1101\/2024.04.09.588766","DOI":"10.1101\/2024.04.09.588766"},{"key":"18_CR117","doi-asserted-by":"publisher","first-page":"174019","DOI":"10.1155\/2011\/174019","volume":"2011","author":"DB Sellem","year":"2011","unstructured":"Sellem DB, Elbayed K, Neuville A et al (2011) Metabolomic characterization of ovarian epithelial carcinomas by HRMAS-NMR spectroscopy. J Oncol 2011:174019. https:\/\/doi.org\/10.1155\/2011\/174019","journal-title":"J Oncol"},{"key":"18_CR118","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/NBM.2901","volume":"26","author":"KM Seln\u00e6s","year":"2013","unstructured":"Seln\u00e6s KM, Gribbestad IS, Bertilsson H et al (2013) Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer \u2013 investigation of a correlation with Gleason score. NMR Biomed 26:600\u2013606. https:\/\/doi.org\/10.1002\/NBM.2901","journal-title":"NMR Biomed"},{"key":"18_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-34025-4_1","volume":"1219","author":"J Serpa","year":"2020","unstructured":"Serpa J (2020) Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a job of several holders. Adv Exp Med Biol 1219:1\u201334. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_1","journal-title":"Adv Exp Med Biol"},{"key":"18_CR120","doi-asserted-by":"publisher","first-page":"39211","DOI":"10.1074\/jbc.M110.156026","volume":"285","author":"J Serpa","year":"2010","unstructured":"Serpa J, Caiado F, Carvalho T et al (2010) Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells. J Biol Chem 285:39211\u201339223. https:\/\/doi.org\/10.1074\/jbc.M110.156026","journal-title":"J Biol Chem"},{"key":"18_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50866-y","volume":"14","author":"SB Shakartalla","year":"2024","unstructured":"Shakartalla SB, Ashmawy NS, Semreen MH et al (2024) 1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer. Sci Rep 14:253. https:\/\/doi.org\/10.1038\/s41598-023-50866-y","journal-title":"Sci Rep"},{"key":"18_CR122","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/NBM.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter B, Bathen TF, Singstad TE et al (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 23:424\u2013431. https:\/\/doi.org\/10.1002\/NBM.1478","journal-title":"NMR Biomed"},{"key":"18_CR123","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/NBM.992","volume":"19","author":"B Sitter","year":"2006","unstructured":"Sitter B, Lundgren S, Bathen TF et al (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30\u201340. https:\/\/doi.org\/10.1002\/NBM.992","journal-title":"NMR Biomed"},{"key":"18_CR124","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/NBM.775","volume":"15","author":"B Sitter","year":"2002","unstructured":"Sitter B, Sonnewald U, Spraul M et al (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15:327\u2013337. https:\/\/doi.org\/10.1002\/NBM.775","journal-title":"NMR Biomed"},{"key":"18_CR125","doi-asserted-by":"publisher","first-page":"10903","DOI":"10.3390\/IJMS252010903","volume":"25","author":"A Skorupa","year":"2024","unstructured":"Skorupa A, Klimek M, Ciszek M et al (2024) Metabolomic analysis of histological composition variability of high-grade serous ovarian cancer using 1H HR MAS NMR spectroscopy. Int J Mol Sci 25:10903. https:\/\/doi.org\/10.3390\/IJMS252010903","journal-title":"Int J Mol Sci"},{"key":"18_CR126","doi-asserted-by":"publisher","first-page":"18160","DOI":"10.1038\/s41598-021-97505-y","volume":"11","author":"A Skorupa","year":"2021","unstructured":"Skorupa A, Po\u0144ski M, Ciszek M et al (2021) Grading of endometrial cancer using 1H HR-MAS NMR-based metabolomics. Sci Rep 11:18160. https:\/\/doi.org\/10.1038\/s41598-021-97505-y","journal-title":"Sci Rep"},{"key":"18_CR127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/CBM-2009-0115","volume":"6","author":"S Srivastava","year":"2009","unstructured":"Srivastava S, Roy R, Singh S et al (2009) Taurine\u2014a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy. Cancer Biomarkers 6:11\u201320. https:\/\/doi.org\/10.3233\/CBM-2009-0115","journal-title":"Cancer Biomarkers"},{"key":"18_CR128","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/BMI.S6794","volume":"6","author":"K Stenman","year":"2011","unstructured":"Stenman K, Stattin P, Stenlund H et al (2011) 1H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples. Biomark Insights 6:39\u201347. https:\/\/doi.org\/10.4137\/BMI.S6794","journal-title":"Biomark Insights"},{"key":"18_CR129","doi-asserted-by":"publisher","unstructured":"Stenman K, Surowiec I, Antti H et al (2010) Detection of local prostate metabolites by HRMAS NMR spectroscopy: a comparative study of human and rat prostate tissues. Magn Reson Insights 4. https:\/\/doi.org\/10.4137\/MRI.S6028","DOI":"10.4137\/MRI.S6028"},{"key":"18_CR130","doi-asserted-by":"publisher","first-page":"e1795","DOI":"10.1002\/CNR2.1795","volume":"6","author":"GS Suri","year":"2023","unstructured":"Suri GS, Kaur G, Carbone GM, Shinde D (2023) Metabolomics in oncology. Cancer Rep 6:e1795. https:\/\/doi.org\/10.1002\/CNR2.1795","journal-title":"Cancer Rep"},{"key":"18_CR131","doi-asserted-by":"publisher","first-page":"20790","DOI":"10.1038\/SREP20790","volume":"6","author":"Y Tian","year":"2016","unstructured":"Tian Y, Xu T, Huang J et al (2016) Tissue metabonomic phenotyping for diagnosis and prognosis of human colorectal cancer. Sci Rep 6:20790. https:\/\/doi.org\/10.1038\/SREP20790","journal-title":"Sci Rep"},{"key":"18_CR132","doi-asserted-by":"publisher","first-page":"20190003","DOI":"10.1259\/BJRCR.20190003","volume":"5","author":"M Tran","year":"2019","unstructured":"Tran M, Latifoltojar A, Neves JB et al (2019) First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma. BJR Case Rep 5:20190003. https:\/\/doi.org\/10.1259\/BJRCR.20190003","journal-title":"BJR Case Rep"},{"key":"18_CR133","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/CANCERS12061644","volume":"12","author":"JM Urman","year":"2020","unstructured":"Urman JM, Herranz JM, Uriarte I et al (2020) Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach. Cancers (Basel) 12:1644. https:\/\/doi.org\/10.3390\/CANCERS12061644","journal-title":"Cancers (Basel)"},{"key":"18_CR134","doi-asserted-by":"publisher","first-page":"e4882","DOI":"10.1002\/NBM.4882","volume":"36","author":"WJM van der Kemp","year":"2023","unstructured":"van der Kemp WJM, Grinde MT, Malvik JO et al (2023) Metabolic profiling of colorectal cancer organoids: a comparison between high-resolution magic angle spinning magnetic resonance spectroscopy and solution nuclear magnetic resonance spectroscopy of polar extracts. NMR Biomed 36:e4882. https:\/\/doi.org\/10.1002\/NBM.4882","journal-title":"NMR Biomed"},{"key":"18_CR135","doi-asserted-by":"publisher","first-page":"e2024357119","DOI":"10.1073\/PNAS.2024357119","volume":"119","author":"FHA van Heijster","year":"2022","unstructured":"van Heijster FHA, Breukels V, Jansen KCFJ et al (2022) Carbon sources and pathways for citrate secreted by human prostate cancer cells determined by NMR tracing and metabolic modeling. Proc Natl Acad Sci USA 119:e2024357119. https:\/\/doi.org\/10.1073\/PNAS.2024357119","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR136","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/S11934-010-0151-3","volume":"12","author":"QN Van","year":"2011","unstructured":"Van QN, Veenstra TD, Issaq HJ (2011) Metabolic profiling for the detection of bladder cancer. Curr Urol Rep 12:34\u201340. https:\/\/doi.org\/10.1007\/S11934-010-0151-3","journal-title":"Curr Urol Rep"},{"key":"18_CR137","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.3390\/MOLECULES26226766","volume":"26","author":"M Vermathen","year":"2021","unstructured":"Vermathen M, von Tengg-Kobligk H, Hungerb\u00fchler MN et al (2021) 1H HR-MAS NMR based metabolic profiling of lung cancer cells with induced and de-induced cisplatin resistance to reveal metabolic resistance adaptations. Molecules 26:6766. https:\/\/doi.org\/10.3390\/MOLECULES26226766","journal-title":"Molecules"},{"key":"18_CR138","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/NBM.3198","volume":"27","author":"AS Wang","year":"2014","unstructured":"Wang AS, Lodi A, Rivera LB et al (2014) HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. NMR Biomed 27:1361\u20131370. https:\/\/doi.org\/10.1002\/NBM.3198","journal-title":"NMR Biomed"},{"key":"18_CR139","doi-asserted-by":"publisher","first-page":"113546","DOI":"10.1016\/j.jpba.2020.113546","volume":"190","author":"S Wang","year":"2020","unstructured":"Wang S, Wen S, Guo P et al (2020) Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues. J Pharm Biomed Anal 190:113546. https:\/\/doi.org\/10.1016\/j.jpba.2020.113546","journal-title":"J Pharm Biomed Anal"},{"key":"18_CR140","unstructured":"Wang Z (2023) Study details | Hyperpolarized 13C pyruvate MRI for treatment response assessment in pancreatic ductal adenocarcinoma | ClinicalTrials.gov. University of California, San Francisco. https:\/\/www.clinicaltrials.gov\/study\/NCT04565327. Accessed 31 Jul 2025"},{"key":"18_CR141","doi-asserted-by":"publisher","first-page":"105831","DOI":"10.18632\/ONCOTARGET.22402","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Lin Y, Liang J et al (2017) NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection. Oncotarget 8:105831. https:\/\/doi.org\/10.18632\/ONCOTARGET.22402","journal-title":"Oncotarget"},{"key":"18_CR142","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2967\/JNUMED.114.141705","volume":"55","author":"DM Wilson","year":"2014","unstructured":"Wilson DM, Kurhanewicz J (2014) Hyperpolarized 13C MR for molecular imaging of prostate cancer. J Nucl Med 55:1567\u20131572. https:\/\/doi.org\/10.2967\/JNUMED.114.141705","journal-title":"J Nucl Med"},{"key":"18_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-6","volume":"8","author":"M Wilson","year":"2009","unstructured":"Wilson M, Davies NP, Brundler MA et al (2009) High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours. Mol Cancer 8:6. https:\/\/doi.org\/10.1186\/1476-4598-8-6","journal-title":"Mol Cancer"},{"key":"18_CR144","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3390\/DIAGNOSTICS13132311","volume":"13","author":"R Woitek","year":"2023","unstructured":"Woitek R, Brindle KM (2023) Hyperpolarized carbon-13 MRI in breast cancer. Diagnostics 13:2311. https:\/\/doi.org\/10.3390\/DIAGNOSTICS13132311","journal-title":"Diagnostics"},{"key":"18_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-66","volume":"9","author":"AJ Wright","year":"2010","unstructured":"Wright AJ, Fellows GA, Griffiths JR et al (2010) Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer 9:66. https:\/\/doi.org\/10.1186\/1476-4598-9-66","journal-title":"Mol Cancer"},{"key":"18_CR146","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/MRM.27879","volume":"82","author":"D Wu","year":"2019","unstructured":"Wu D, Zhang J (2019) Evidence of the diffusion time dependence of intravoxel incoherent motion in the brain. Magn Reson Med 82:2225\u20132235. https:\/\/doi.org\/10.1002\/MRM.27879","journal-title":"Magn Reson Med"},{"key":"18_CR147","first-page":"33","volume":"2","author":"ZSA Zahra","year":"2024","unstructured":"Zahra ZSA (2024) Nuclear magnetic resonance (NMR): principle, applications, types, and uses in metabolite identification and medical biotechnology. Curr Clin Med Educ 2:33\u201348","journal-title":"Curr Clin Med Educ"},{"key":"18_CR148","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3390\/MOLECULES26082266","volume":"26","author":"O Zidi","year":"2021","unstructured":"Zidi O, Souai N, Raies H et al (2021) Fecal metabolic profiling of breast cancer patients during neoadjuvant chemotherapy reveals potential biomarkers. Molecules 26:2266. https:\/\/doi.org\/10.3390\/MOLECULES26082266","journal-title":"Molecules"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:44Z","timestamp":1783768604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":148,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}